This site is intended for health professionals only

At the heart of general practice since 1960

Clopidogrel before angioplasty improves outcomes

Patients who receive clopidogrel before undergoing percutaneous coronary intervention (PCI) have better clinical outcomes, a systematic review suggests.

Data from 26 trials showed patients given a loading dose of clopidogrel before pre-PCI coronary angiography had an initial patency of 34.3%, significantly higher than the 25.8% in patients who did not receive the drug.

Pre-treatment with clopidogrel was also an independent predictor of early reperfusion and lowered the risk of death and reinfarction.

Circulation 2008 early online publication

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say